Skip to main content

Table 2 Overview of clinical study details

From: Safety and efficacy of cell therapies in pediatric heart disease: a systematic review and meta-analysis

Author (year)

Study design

Human characteristics

Intervention characteristics

Outcome measures

Study type

Disease

Age

Cell type; source (origin)

Total dose (cells/kg); route; timing of delivery; frequency

Timing of assessment

Ventricular function mode of assessment

Burkhart et al. [21]

Case report

HLHS

4 months

Umbilical cord blood (autologous)

3.0 × 106; intramyocardial; at time of stage II palliation; once

Baseline and 3 months

Echo

Burkhart et al. [22]

Phase I

HLHS

3–6 months

Umbilical cord blood (autologous)

3.0 × 106; intramyocardial; during stage II palliation; once

Baseline, discharge, 1 month, 3 months, and 6 months

Echo

Eitoku et al. [23]

Phase I/II

SV

5–70 months

Cardiac (autologous)

3.0 × 105; intracoronary; 1-month post-staged palliation; once

Baseline, 3 years

Cardiac MRI

Ishigami et al. (2014)

Phase I

HLHS

1.5 years

Cardiac (autologous)

3.0 × 105; intracoronary; 1-month post-staged palliation; once

Baseline, 3 months, 6 months, 12 months, and 18 months

Echo, cardiac MRI

Ishigami et al. [24]

Phase II

SV

1.2–4.2 years

Cardiac (autologous)

3.0 × 105; intracoronary; 1-month post-staged palliation; once

Baseline, 3 months

Cardiac MRI

Pincott et al. [25]

Phase I/II

DCM

1–16 years

Bone marrow (autologous)

5.4 × 107b; intracoronary; within 1 h of harvest; once

Baseline, 6 moths

Cardiac MRI, Cath

Qureshi et al. [26]

Case report

HLHS

25 years

Bone marrow (autologous)

2.0 × 106; intracoronary; within 3 h of harvest; once

Baseline, 1 month, 3 months, 6 months

Echo

Rivas et al. [27]

Case report

DCM

3–4 months

Bone marrow (autologous)

8.35 × 106a; intracoronary; 2 h post-isolation; once

Baseline, 1 week, 4 weeks, 8 weeks, and 17 weeks

Echo

Rupp et al. [28]

Case report

HLHS

11 months

Bone marrow (autologous)

DNR; intracoronary; day of harvest; once

Baseline, 3 months

Echo, cardiac MRI

Rupp et al. [29]

Phase I/II

DCM

4 months-16 years

Bone marrow (autologous)

DNR; intracoronary; day of harvest; once

Baseline, 2–3 months, 24–52 months

DNR

Sano et al. [30]

Phase I

SV

8 months-3.1 years

Cardiac (autologous)

3.0 × 105; intracoronary; intraoperative (stage II or III); once

Baseline, 1 year, 2 years post-palliation

Echo

Tarui et al. [31]

Phase I

HLHS

1.5 years

Cardiac (autologous)

3.0 × 105; intracoronary; 1-month post-staged palliation; once

Baseline, 36 months

Cardiac MRI

Zschirnt et al. [32]

Case report

DCM

DNR

Bone marrow (autologous)

2.4 × 107; intracoronary; DNR; once

Baseline, 4 months

Cardiac MRI

  1. HLHS hypoplastic left heart syndrome, SV single ventricle, DCM dilated cardiomyopathy, DNR did not report
  2. aAbsolute cell count
  3. bDose obtained based on additional study cited within paper